Abstract:The transient receptor potential vanilloid type 1 (TRPV1) is a heat-activated cation channel protein, which contributes to inflammation, acute and persistent pain. Antagonists of human TRPV1 (hTRPV1) represent a novel therapeutic approach for the treatment of pain. Developing various antagonists of hTRPV1, however, has been hindered by the unavailability of a 3D structure of hTRPV1. Recently, the 3D structures of rat TRPV1 (rTRPV1) in the presence and absence of ligand have been reported as determined by cryo-EM. rTRPV1 shares 85.7% sequence identity with hTRPV1. In the present work, we constructed and reported the 3D homology tetramer model of hTRPV1 based on the cryo-EM structures of rTRPV1. Molecular dynamics (MD) simulations, energy minimizations, and prescreen were applied to select and validate the best model of hTRPV1. The predicted binding pocket of hTRPV1 consists of two adjacent monomers subunits, which were congruent with the experimental rTRPV1 data and the cyro-EM structures of rTRPV1. The detailed interactions between hTRPV1 and its antagonists or agonists were characterized by molecular docking, which helped us to identify the important residues. Conformational changes of hTRPV1 upon antagonist/agonist binding were also explored by MD simulation. The different movements of compounds led to the different conformational changes of monomers in hTRPV1, indicating that TRPV1 works in a concerted way, resembling some other channel proteins such as aquaporins. We observed that the selective filter was open when hTRPV1 bound with an agonist during MD simulation. For the lower gate of hTRPV1, we observed large similarities between hTRPV1 bound with antagonist and with agonist. A five-point pharmacophore model based on several antagonists was established, and the structural model was used to screen in silico for new antagonists for hTRPV1. By using the 3D TRPV1 structural model above, the pilot in silico screening has begun to yield promising hits with activity as hTRPV1 antagonists, several of which showed substantial potency.

Structural insights into TRPV2 activation by small molecules

Molecular Mechanism of TRPV1 Activation by Capsaicin

Rational Design and Validation of a Vanilloid-Sensitive TRPV2 Ion Channel.

Exploring Functional Roles of TRPV1 Intracellular Domains with Unstructured Peptide-Insertion Screening.

A Structural Framework for the Polymodal Pain Sensor TRPV1

Structural mechanism underlying capsaicin binding and activation of the TRPV1 ion channel

Structural Pharmacology of TRPV4 Antagonists

TRPV3 activation by different agonists accompanied by lipid dissociation from the vanilloid site

A Set of Novel Capsaicin Analogs As Molecular Ruler for Conformational Change of the TRPV1 Ligand-Binding Pocket

Endocannabinoid activation of the TRPV1 ion channel is distinct from activation by capsaicin

Structural insights on TRPV5 gating by endogenous modulators

Molecular mechanism of TRPV2 channel modulation by cannabidiol

Activation of TRPV1 by Capsaicin Analogs with a Shorter or Longer Neck

Structural Basis of Trpv2 Channel Gating Investigated with Cryo-Em

Cannabinoid non-cannabidiol site modulation of TRPV2 structure and function

A First Look into the 3D Structure of the TRPV2 Channel by Single-Particle Cryo-Em

Structure of the TRPV1 ion channel determined by electron cryo-microscopy

Structures of TRPV2 in Distinct Conformations Provide Insight into Role of the Pore Turret

TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action

Functional and structural insights into activation of TRPV2 by weak acids

Insight into the Structure of Tetramer Htrpv1 from Homology Modeling, Molecular Docking, Molecular Dynamics Simulation and Virtual Screening